SCHEMBL17847501

SCHEMBL17847501

Cc1ccc(N=C=O)c(Sc2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.41
▸ HTR1A P08908 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.38
▸ TDP1 Q9NUW8 3/20 0.38
▸ TRPA1 O75762 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.35
▸ HPGD P15428 3/20 0.35
▸ AKR1B1 P15121 1/20 0.34
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ MAPT P10636 6/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ LMNA P02545 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CSF1R P07333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3009802 0.87 CYP3A4 (0.44) CYP3A4HTR1AHTR3ATDP1TRPA1
SCHEMBL19712975 0.86 SLC6A4 (0.38) CYP3A4TDP1TRPA1ALDH1A1HPGD
SCHEMBL19712969 0.81 PDE7A (0.47) L3MBTL1MEN1KMT2ALMNAMAPK1
SCHEMBL19712961 0.81 ALDH1A1 (0.38) CYP3A4L3MBTL1TDP1ALDH1A1HPGD
SCHEMBL17847474 0.81 GABRA1 (0.36) CYP3A4L3MBTL1TDP1ALDH1A1HPGD
SCHEMBL28479110 0.80 CYP3A4 (0.47) CYP3A4HTR1AHTR3AL3MBTL1TRPA1
SCHEMBL624408 0.80 CYP3A4 (0.44) CYP3A4HTR1AHTR3AL3MBTL1TDP1
SCHEMBL29466687 0.80 CYP3A4 (0.44) CYP3A4TDP1TRPA1ALDH1A1HPGD
SCHEMBL484027 0.80 CYP3A4 (0.44) CYP3A4TDP1TRPA1ALDH1A1HPGD
SCHEMBL17847448 0.80 CYP3A4 (0.33) CYP3A4TDP1TRPA1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107223121-B Wet stable holographic media 科思创德国股份有限公司 2020-10-27 — — CN disclosed
EP-3233791-B1 MOISTURE STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2020-08-12 — — EP disclosed
US-10329244-B2 Moisture-stable holographic media COVESTRO DEUTSCHLAND AG (DE) 2019-06-25 — — US disclosed
US-20170362165-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2017-12-21 — — US disclosed
EP-3233791-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA Covestro Deutschland AG (DE) 2017-10-25 — — EP disclosed
WO-2016096641-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2016-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329244-B2 Moisture-stable holographic media NEFM, MDM4, BHMT2 CYP3A4 3992/4885HTR1A 856/4885HTR3A 1644/4885
US-20170362165-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA NEFM, MDM4, BHMT2 CYP3A4 3992/4885HTR1A 856/4885HTR3A 1644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback